Involvement of PDGF in Fibrosis and Scleroderma: Recent Insights from Animal Models and Potential Therapeutic Opportunities
- 882 Downloads
Fibrosis is the principal characteristic of the autoimmune disease known as scleroderma or systemic sclerosis (SSc). Studies published within the last three years suggest central involvement of platelet-derived growth factors (PDGFs) in SSc-associated fibrosis. PDGFs may also be involved in SSc-associated autoimmunity and vasculopathy. The PDGF signaling pathway is well understood and PDGF receptors are expressed on collagen-secreting fibroblasts and on mesenchymal stem and/or progenitor cells that may affect SSc in profound and unexpected ways. Although much work remains before we fully understand how PDGFs are involved in SSc, there is much interest in using PDGF inhibitors as a therapeutic approach to SSc.
KeywordsPDGF Scleroderma Fibrosis Mouse model Animal models Pericyte Imatinib Neutralizing antibody Therapeutic
No potential conflicts of interest relevant to this article were reported.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 37.•• Dulauroy S, Di Carlo SE, Langa F, et al. Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med. 2012;18:1262–70. This article describes how ADAM12+ perivascular cells, which express multipotent mesenchymal stem/progenitor cell markers including PDGFRα and β, are activated after acute injury to become progenitors of collagen-overproducing cells in vivo CrossRefGoogle Scholar
- 39.• Meinecke AK, Nagy N, Lago GD, et al. Aberrant mural cell recruitment to lymphatic vessels and impaired lymphatic drainage in a murine model of pulmonary fibrosis. Blood. 2012;119:5931–42. Unlike blood vessels, lymphatic vessels normally lack mural cells (pericytes and smooth muscle cells). By using a bleomycin-induced pulmonary fibrosis model, the authors show that PDGFRβ+ mural cells cover lymphatics in fibrotic lungs, which impairs drainage capacity. Fibrosis and lymphatic function are improved by inhibiting PDGF signaling.PubMedCrossRefGoogle Scholar
- 40.•• Krautler NJ, Kana V, Kranich J, et al. Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell. 2012;150:194–206. This article provides convincing evidence that follicular dendritic cells (FDCs) arise from ubiquitous perivascular precursors, which express PDGFRβ, as mural cells do. When the isolated PDGFRβ+ cells were transplanted into FDC-lacking mice, followed by stimulation to differentiate into FDCs, mature functional FDCs were observed de novo.PubMedCrossRefGoogle Scholar
- 44.• Olson LE, Soriano P. PDGFRbeta Signaling Regulates Mural Cell Plasticity and Inhibits Fat Development. Dev Cell. 2011;20:815–26. This article demonstrates that hyperresponsive PDGFRβ signaling induces an autoinflammatory gene signature in pericytes and other mesenchyme-derived cells. This effect is distinct from the multiorgan fibrosis observed with hyperresponsive PDGFRα signaling (see Ref. 17).PubMedCrossRefGoogle Scholar
- 55.• Liao CH, Akazawa H, Tamagawa M, et al. Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest. 2010;120:242–53. The authors use a mouse model to show that atrial fibrosis induced by pressure-overload can be attenuated by injection of a neutralizing antibody specific for PDGFRα. On the other hand, administration of PDGF-AA promotes atrial fibrosis.PubMedCrossRefGoogle Scholar